Best Clinical Genomics Companies in India
The 63 best Clinical Genomics companies in India in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: LifeCell.
- Mordor Intelligence
- ResearchAndMarkets.com
Ranked: Best Clinical Genomics companies in India
| # | Company | Revenue | Disclosed funding | Revenue YoY | Employees | Founder | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Bigtec Labs Developer of point-of-care solutions for nucleic acid amplification tests | $122M FY2025 | — | +22% | 633 633 → 317 (-50%) | Chandrasekhar Nair Co-Founder & CTO | Funding Raised | 227 patents Portable microfluidic PCR chips for point‑of‑care nucleic‑acid amplification and diagnostics | — |
| 2 | LifeCell A stem cell banking company specializing in cord blood and tissue preservation 83Fin. health top 11%Tech top 14%Moat top 20%Market top 24% All 10 signals ▾Fin. healthtop 11% Techtop 14% Moattop 20% Markettop 24% Fundingtop 36% Growthtop 46% Producttop 49% Talentbottom 49% Globalbottom 37% Newsbottom 21% Fin. health: Revenue ~$101M (FY2022) · Net margin 45.7% Tech: 46 technologies across 7/8 capability areas · Cloud: Amazon Alb, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 83/100 | $101M FY2025 | $61M | +146% | 1,188 1,188 → 2,658 (+124%) | Mayura Jain CEO & Managing Director | Series B | — | 1 partnership |
| 3 | Mylab Developer of diagnostic kits for pathogen detection and viral load monitoring | $18M FY2024 | $132K | +23% | 351 351 → 248 (-29%) | Hasmukh Rawal Co-Founder & Managing Director | Seed | — | — |
| 4 | Datar Genetics Provider of liquid biopsy-based cancer diagnostic test | $12M FY2025 | $742K | +31% | 175 | Rajan Datar Founder | Early Stage | — | — |
| 5 | Navigene Provider of diagnosing genetic medical conditions and recommending preventive care | $4M FY2025 | $251K | +229% | 16 | Rishi Dixit Co Founder & CEO | Seed | — | — |
| 6 | Genes2me Provider of personalized healthcare by genetics and molecular diagnostics | $3M FY2025 | — | -20% | 66 | — | Funding Raised | — | — |
| 7 | OncoStem Developer of prognostic tests for the detection of cancer | $1M FY2025 | $9M | +40% | 19 | Manjiri Bakre Founder & CEO | Series A | — | — |
| 8 | NeoGen Labs Neonatal diagnostic solutions for the detection of inborn errors of metabolism | $901K FY2025 | $458K | +7% | 25 25 → 37 (+48%) | Thomas Mookken Co-Founder & CEO | Seed | — | — |
| 9 | Dhiti Omics Provides precision molecular diagnostic services | $857K FY2025 | $278K | +342% | — | — | Seed | — | — |
| 10 | HaystackAnalytics Provider of genomics technology for personalized clinical decisions 60Growth top 17%Talent top 28%Moat top 38%Funding top 47% All 10 signals ▾Growthtop 17% Talenttop 28% Moattop 38% Fundingtop 47% Markettop 48% Techtop 49% Innovationbottom 47% Patentsbottom 47% Fin. healthbottom 45% Globalbottom 39% Growth: Revenue +177% YoY · Web rank 10,000,000 → 5,000,000 YoY Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 60/100 | $838K FY2025 | $1M | +177% | 151 151 → 266 (+76%) | Kiran Kondabagil Co-Founder | Seed | 3 patents Molecular diagnostics for pathogen and antibiotic‑resistance gene detection | 1 award |
| 11 | FutureMed Provider of services related to wellness, pharmacogenomics, and clinical genomics | $611K FY2025 | — | -23% | — | Chandni Luthra Co-Founder | Unfunded | — | — |
| 12 | Indna Lifesciences Developer of DNA-based molecular detection tests and companion diagnostics for personalized medicine | $522K FY2025 | $497K | +11% | 1 | Paromita Chattoraj Co-Founder & Director | Seed | — | — |
| 13 | Genome Life Sciences Provider of services for next-gen sequencing and big data analysis | $390K FY2025 | — | +7% | — | Periannan Senapathy Founder & CEO | Unfunded | — | — |
| 14 | Bioheaven 360 Provider of AI-powered genomics diagnostics tools for risk prediction of diseases | $232K FY2025 | $264K | +5% | 5 | — | Seed | — | — |
| 15 | XCyton Diagnostics Provider of molecular diagnostic products and services | $188K FY2025 | $6M | -85% | 23 | — | Early Stage | — | — |
| 16 | AyuGen Provider of genetic testing and molecular diagnostics | $181K FY2025 | — | +58% | — | Manish Pungliya Founder & Director | Unfunded | — | — |
| 17 | DeepKnomics Developer of products in clinical diagnostics and immuno-oncology space | $172K FY2025 | — | +72% | — | Swapnil Mahajan Co-Founder | Unfunded | — | — |
| 18 | Tvaster Genkalp Developer of epigenetic-based liquid biopsy tests for cancer detection. | $109K FY2025 | $1M | +9% | 4 | Srikar Raman Co-Founder & CEO | Seed | 3 patents Epigenetic diagnostic kits detecting carcinomas via methylation markers without sequencing | — |
| 19 | CrisprBits Developer of diagnostic tests based on gene editing technology 42Growth top 21%Talent top 28%Tech top 36%News top 36% All 11 signals ▾Growthtop 21% Talenttop 28% Techtop 36% Newstop 36% Moattop 47% Patentsbottom 46% Innovationbottom 44% Fundingbottom 43% Fin. healthbottom 38% Globalbottom 37% Marketbottom 25% Growth: Revenue +249% YoY · Fresh capital in last 24 mo Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 42/100 | $99K FY2025 | $447K | +249% | — | Bharat Jobanputra Co-Founder | Seed | 4 patents CRISPR-based diagnostic assays for SARS‑CoV‑2 variant detection and host susceptibility testing | 1 job opening · 2 launchs |
| 20 | Kyvor Genomics-based precision cancer diagnostics | $61K FY2024 | $160K | +15% | 11 | Abilesh Malli Gunasekar Founder & CEO | Seed | — | — |
| 21 | Positive Bioscience Provider of DNA tests for cancer treatment & hereditary cancer screening | $43K FY2025 | $466K | -91% | 11 | Samarth Jain Co-Founder & CEO | Seed | — | — |
Top 12 Clinical Genomics companies in India
#1
Seed · Mumbai, Maharashtra · founded 2018 · 151 employees$1Mraised▾
Provider of genomics technology for personalized clinical decisions. It offers clinical-genomics diagnostic tests which include Universal Infectious Diseases Test (UID) a next-generation sequencing powered, culture-free test capable of detecting bacterial and fungal pathogens and infexn test is s a comprehensive genomic solution for rapid identification of pathogens and antimicrobial resistance directly from clinical samples.
- Sep 2025Seed$5M
- Jan 2024Seed$9M
- Jun 2023Angel$190.2K
- Jul 2022Angel$2.1M
#2
Seed · Delhi, Delhi · founded 2020$446.7Kraised▾
Developer of diagnostic tests based on gene editing technology. It offers CRISPR-based diagnostic tests for infectious diseases, inherited diseases, cancer, and predicts genetic diseases. It is also used in animal and cell models, agriculture, biofuels, therapeutics, and industries.
- Nov 2025Seed$3M
- Feb 2023Seed$250K
- Aug 2021Seed$196.7K
#3
Series B · Chennai, Tamil Nadu · founded 2004 · 1188 employees$61.2Mraised▾
A stem cell banking company specializing in cord blood and tissue preservation. The company provides stem cell banking services focused on preserving umbilical cord blood and tissue stem cells for potential future medical treatments. It also offers lab tests, allografts, and skincare products through its platform.
- Mar 2024Series B$22.1M
- Sep 2021Series B$30.5M
- Feb 2013Series A$6.4M
- Jan 2007Seed$1.1M
#4
Seed · Chennai, Tamil Nadu · founded 2021 · 4 employees$1.3Mraised▾
{}
- Apr 2025Seed$1.2M
- Sep 2023Seed$1.3M
- Grant (prize money)—
#5
Early Stage · Nashik, Maharashtra · founded 1992 · 175 employees$742.3Kraised▾
Provider of liquid biopsy-based cancer diagnostic test. The products include trublood which is a non-invasive biopsy to check for malignancy, celldx for genome analysis of tumor, exacta for personalized treatment based on tumor analysis, and chemoscale to evaluate resistance to chemotherapy drugs by in-vitro analysis.
- Aug 2024Unattributed$3M
#6
Acquired · Bangalore, Karnataka · founded 2000 · 375 employees$34.9Mraised▾
Provider of sequence-based diagnostics and clinical genomic data interpretation services intended to identify the right therapy for cancer through genomic testing. The company's services offer informatics products and services for research biologists, chemists and toxicologists that combine advanced visualization, predictive systems modeling, data integration and scientific content management, enabling doctors to identify individuals and families with a high risk of hereditary cancer and provide them with personalized surveillance and risk-reduction measures.
#7
Series A · Bengaluru, Karnataka · founded 2011 · 19 employees$9Mraised▾
Developer of prognostic tests for the detection of cancer. The company's flagship product is CanAssist-Breast, which uses a proprietary Artificial Intelligence-based statistical model to identify the patient's risk of breast cancer recurrence. Also, it provides additional information about the tumor, based on which the cancer treatment can be customized.
- Sep 2017Series A$6M
- 2011Seed$3M
#8
Early Stage · Bengaluru, Karnataka · founded 1993 · 23 employees$5.6Mraised▾
Provider of molecular diagnostic products and services. The company provides medical diagnosis for critical care infections, offering a wide array of immunodiagnostic and molecular diagnostic services, as well as clinical tests.
- Mar 2014Unattributed$167K
- Nov 2011Unattributed$4.5M
- Dec 2007Unattributed$380.4K
- Mar 2007Unattributed$229.6K
#9
Series A · Bengaluru, Karnataka · founded 2013 · 9 employees$5.1Mraised▾
Developers of cost-effective biomedical devices. Their BioScoop biopsy system is a device for soft tissue core biopsy. It enables physicians achieve definitive tissue capture using a novel needle design, advanced needle-tissue characterization and automated control. Its other product, BxSeal is a safety feature offered to the biopsy device to assist in concurrently delivering a haemostatic agent inside the biopsy track to reduce the risk of internal haemorrhage.
- May 2016Series A$251.7K
- Sep 2014Series A$2.8M
- 2014Grant (prize money)—
- Jul 2013Series A$2.1M
#10
Seed · Delhi, Delhi · founded 2018 · 5 employees$264.4Kraised▾
Provider of AI-powered genomics diagnostics tools for risk prediction of diseases. The company uses AI and Machine Learning based patient classification model that can be used in a clinical setup for early detection and classification of osteoporosis.
- Jan 2023Seed$122.9K
- Jun 2022Angel$114.3K
- May 2021Angel$27.2K
#11
Seed · Bengaluru, Karnataka · founded 2014$278.4Kraised▾
Provides precision molecular diagnostic services. The company employs state-of-the-art technologies including Sanger Sequencing, Next Generation Sequencing, and Microarrays to decode an individual’s genome and identify underlying genetic clues. This help clinicians to predict, prevent and pre-empt diseases better and enables them to make an informed choice for the patients.
- Oct 2022Angel$105.1K
- Mar 2016Angel$173.3K
#12
Seed · Pune, Maharashtra · founded 2016 · 351 employees$131.5Kraised▾
Developer of diagnostic kits for pathogen detection and viral load monitoring. It offers a wide range of diagnostic kits to detect and monitor a wide range of human ailments, including infections, cancer, genetic disorders, and blood screening. It offers Compact x automation solution integrates automated sample preparation and assay setup with detection, Compact xL is a sample-to-PCR ready system., and CompactQ a fluorescence quantitative PCR detection system.
- Jun 2023Seed—
- Apr 2020Grant (prize money)$131.5K
- Apr 2020Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Clinical Genomics coverage by sub-theme.
Regulatory-risk over time flat
Funding & growth over time
funding rising · growth rising
How research on Diagnostics is moving in India
A read on the academic research around Diagnostics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,535 India-affiliated papers.
- All India Institute of Medical Sciences98
- Program for Appropriate Technology in Health49
- Post Graduate Institute of Medical Education and Research46
- Manipal Academy of Higher Education41
- Kasturba Medical College, Manipal33
- Point-of-care testing11→41
- Liquid biopsy4→25
- Biomarker2→20
- Computational biology1→16
- Point of care9→23
- Liquid biopsy5→129
- Point-of-care testing26→98
- Cancer3→63
- Biopsy5→52
- Biomarker1→40
- Liquid biopsy4→56
- Point-of-care testing22→58
- Diagnostic test6→30
- Cancer2→25
- Biomarker4→25
Where diagnostics is researched across India
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing diagnostics patents in India
India diagnostics patent filing is steady — 1 filings from 1 assignees (2022–2022), led by Bhattacharya Jaydeep; annual filings 1→1.
- Bhattacharya Jaydeep1
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.